Xiaoming Yang
Corporate Officer/Principal bei TRANSCENTA HOLDING LIMITED
Profil
Xiaoming Yang's current job is as an Executive VP-Process & Product Development at Transcenta Holding Ltd.
Dr. Yang's former jobs include being a Scientific Director-Process & Product Development at Amgen, Inc. from 2003 to 2013, and being the Head-Commercial Production at Allergan Ltd.
(Ireland) from 2001 to 2003.
Dr. Yang's education history includes a doctorate degree from Rutgers State University of New Jersey in 2001, an undergraduate degree from Chengdu University of Science & Technology in 1984, and an undergraduate degree from the Institute of Process Engineering in 1987.
Aktive Positionen von Xiaoming Yang
Unternehmen | Position | Beginn |
---|---|---|
TRANSCENTA HOLDING LIMITED | Corporate Officer/Principal | 01.02.2021 |
Ehemalige bekannte Positionen von Xiaoming Yang
Unternehmen | Position | Ende |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01.06.2013 |
ALLERGAN PLC | Corporate Officer/Principal | 01.06.2003 |
Ausbildung von Xiaoming Yang
Chengdu University of Science & Technology | Undergraduate Degree |
Institute of Process Engineering | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TRANSCENTA HOLDING LIMITED | Health Technology |
AMGEN INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |